Tenax Therapeutics (TENX) Net Cash Flow (2010 - 2026)
Tenax Therapeutics recorded quarterly Net Cash Flow of $21.2 million in Q1 2026, up 1284.96% quarter-over-quarter from -$1.8 million in Q4 2025, and up 27.99% year-over-year from $16.6 million in Q1 2025.
Tenax Therapeutics' Net Cash Flow history runs 17 years deep, the most recent figure standing at $21.2 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 27.99% year-over-year to $21.2 million; the TTM figure through Mar 2026 stood at $7.4 million (down 92.57% YoY), while the FY2025 annual figure was $2.7 million, down 96.81% from the prior year.
- Net Cash Flow came in at $21.2 million for Q1 2026 at Tenax Therapeutics, up from -$1.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $88.9 million in Q3 2024 to a low of -$6.1 million in Q3 2025.
- A 5-year average of $6.7 million and a median of -$1.7 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 4048.17% in 2024 and fell as far as 206.87% in 2024.
- Tenax Therapeutics' Net Cash Flow stood at -$1.7 million in 2022, then increased by 19.81% to -$1.3 million in 2023, then sank by 155.58% to -$3.4 million in 2024, then jumped by 48.13% to -$1.8 million in 2025, then soared by 1284.96% to $21.2 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $21.2 million, -$1.8 million, and -$6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 21.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.20 Mn |
| Mar 31, 2026 | 21.20 Mn |
| Dec 31, 2025 | -1.79 Mn |
| Dec 31, 2025 | -1.79 Mn |
| Sep 30, 2025 | -6.14 Mn |
| Sep 30, 2025 | -6.14 Mn |
| Jun 30, 2025 | -5.92 Mn |
| Jun 30, 2025 | -5.92 Mn |
| Mar 31, 2025 | 16.56 Mn |
| Mar 31, 2025 | 16.56 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Sep 30, 2024 | 88.93 Mn |
| Sep 30, 2024 | 88.93 Mn |
| Jun 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -3.13 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | -1.35 Mn |
| Dec 31, 2023 | -1.35 Mn |
| Sep 30, 2023 | -2.25 Mn |
| Sep 30, 2023 | -2.25 Mn |
| Jun 30, 2023 | -1.02 Mn |
| Jun 30, 2023 | -1.02 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Dec 31, 2022 | -1.68 Mn |
| Dec 31, 2022 | -1.68 Mn |
| Sep 30, 2022 | -3.42 Mn |
| Sep 30, 2022 | -3.42 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | -2.72 Mn |
| Mar 31, 2022 | -2.72 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Sep 30, 2021 | 6.68 Mn |
| Sep 30, 2021 | 6.68 Mn |
| Jun 30, 2021 | -1.87 Mn |
| Jun 30, 2021 | -1.87 Mn |
| Mar 31, 2021 | -2.71 Mn |
| Mar 31, 2021 | -2.71 Mn |
| Dec 31, 2020 | -1.99 Mn |
| Dec 31, 2020 | -1.99 Mn |
| Sep 30, 2020 | 4.15 Mn |
| Sep 30, 2020 | 4.15 Mn |
| Jun 30, 2020 | -273,374.00 |
| Jun 30, 2020 | -273,374.00 |
| Mar 31, 2020 | -547,314.00 |
| Mar 31, 2020 | -547,314.00 |
| Dec 31, 2019 | -1.74 Mn |
| Dec 31, 2019 | -1.74 Mn |
| Sep 30, 2019 | -1.76 Mn |
| Sep 30, 2019 | -1.76 Mn |
| Jun 30, 2019 | -1.91 Mn |
| Jun 30, 2019 | -1.91 Mn |
| Mar 31, 2019 | -2.05 Mn |
| Mar 31, 2019 | -2.05 Mn |
| Dec 31, 2018 | 9.02 Mn |
| Dec 31, 2018 | 9.02 Mn |
| Sep 30, 2018 | -555,695.00 |
| Sep 30, 2018 | -555,695.00 |
| Jun 30, 2018 | 909,638.00 |
| Jun 30, 2018 | 909,638.00 |
| Mar 31, 2018 | 1.39 Mn |
| Mar 31, 2018 | 1.39 Mn |
| Dec 31, 2017 | -159,073.00 |
| Dec 31, 2017 | -159,073.00 |
| Sep 30, 2017 | -469,803.00 |
| Sep 30, 2017 | -469,803.00 |
| Jun 30, 2017 | -4.79 Mn |
| Jun 30, 2017 | -4.79 Mn |
| Mar 31, 2017 | -2.97 Mn |
| Mar 31, 2017 | -2.97 Mn |
| Dec 31, 2016 | 9.27 Mn |
| Dec 31, 2016 | 9.27 Mn |
| Sep 30, 2016 | -1.21 Mn |
| Sep 30, 2016 | -1.21 Mn |
| Jun 30, 2016 | -1.33 Mn |
| Jun 30, 2016 | -1.33 Mn |
| Mar 31, 2016 | -397,935.00 |
| Mar 31, 2016 | -397,935.00 |
| Dec 31, 2015 | -4.27 Mn |
| Dec 31, 2015 | -4.27 Mn |
| Sep 30, 2015 | -3.57 Mn |
| Sep 30, 2015 | -3.57 Mn |
| Jun 30, 2015 | 31.37 Mn |
| Jun 30, 2015 | 31.37 Mn |
| Jul 31, 2014 | -36.36 Mn |
| Jul 31, 2014 | -36.36 Mn |
| Apr 30, 2014 | 51.98 Mn |
| Apr 30, 2014 | 51.98 Mn |
| Jan 31, 2014 | 3.80 Mn |
| Jan 31, 2014 | 3.80 Mn |
| Oct 31, 2013 | -1.53 Mn |
| Oct 31, 2013 | -1.53 Mn |
| Jul 31, 2013 | 3.29 Mn |
| Jul 31, 2013 | 3.29 Mn |
| Apr 30, 2013 | -45,283.00 |
| Apr 30, 2013 | -45,283.00 |
| Jan 31, 2013 | -682,702.00 |
| Jan 31, 2013 | -682,702.00 |
| Oct 31, 2012 | -1.18 Mn |
| Oct 31, 2012 | -1.18 Mn |
| Jul 31, 2012 | 811,258.00 |
| Jul 31, 2012 | 811,258.00 |
| Apr 30, 2012 | -1.40 Mn |
| Apr 30, 2012 | -1.40 Mn |
| Jan 31, 2012 | 1.28 Mn |
| Jan 31, 2012 | 1.28 Mn |
| Oct 31, 2011 | -1.99 Mn |
| Oct 31, 2011 | -1.99 Mn |
| Jul 31, 2011 | 3.05 Mn |
| Jul 31, 2011 | 3.05 Mn |
| Apr 30, 2011 | 429,604.00 |
| Apr 30, 2011 | 429,604.00 |
| Jan 31, 2011 | -314,827.00 |
| Jan 31, 2011 | -314,827.00 |
| Oct 31, 2010 | -1.89 Mn |
| Oct 31, 2010 | -1.89 Mn |
| Jul 31, 2010 | 2.10 Mn |
| Jul 31, 2010 | 2.10 Mn |